Stock listing
NYSE American:AIM AIM ImmunoTech Inc. Stock
Home listing (NYSE American) of AIM ImmunoTech Inc.
Follow AIM ImmunoTech Inc. into a list and get an email when it puts out news.
Share price · AMEX:AIM
$0.155 USD -0.007 (-4.0%)
Close on Oct 30, 2026
- Day range
- $0.155 – $0.164 USDOct 30, 2026
- Volume
- 379,143 sharesOct 30, 2026
- Market cap
- $6.16M USDAt the close on Oct 30, 2026 · price × 39.89M shares outstanding
- 52-week range
- $0.150 – $2.228 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $1.04M USDMedian day 1.04M shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NYSE American:AIM · Home | $0.155 USD | -0.007 (-4.0%) | 379,143 | $0.164 | $0.164 | $0.155 | $0.161 | Close on Oct 30, 2026 |
| LSE:0A4Y | $0.169 USD | +0.011 (+6.6%) | 2,188 | $0.162 | $0.170 | $0.162 | $0.159 | Close on Oct 27, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · AMEX:AIM · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.155 | -0.007 | -4.0% | $0.164 | $0.164 | $0.155 | 379,143 | |
| $0.161 | -0.004 | -2.4% | $0.166 | $0.168 | $0.160 | 262,625 | |
| $0.165 | -0.001 | -0.7% | $0.168 | $0.170 | $0.165 | 169,452 | |
| $0.166 | +0.002 | +1.5% | $0.167 | $0.170 | $0.164 | 200,786 | |
| $0.164 | +0.008 | +4.8% | $0.157 | $0.169 | $0.154 | 768,343 | |
| $0.156 | -0.005 | -2.9% | $0.165 | $0.168 | $0.150 | 918,299 | |
| $0.161 | -0.009 | -5.3% | $0.172 | $0.172 | $0.161 | 402,244 | |
| $0.170 | +0.004 | +2.3% | $0.170 | $0.172 | $0.167 | 232,305 | |
| $0.166 | +0.003 | +1.9% | $0.163 | $0.170 | $0.163 | 268,854 | |
| $0.163 | -0.005 | -3.0% | $0.171 | $0.174 | $0.161 | 505,884 | |
| $0.168 | -0.002 | -1.3% | $0.173 | $0.174 | $0.166 | 348,760 | |
| $0.170 | +0.009 | +5.3% | $0.160 | $0.176 | $0.160 | 1,025,851 | |
| $0.162 | -0.008 | -4.8% | $0.169 | $0.170 | $0.161 | 559,016 | |
| $0.170 | -0.008 | -4.2% | $0.178 | $0.179 | $0.169 | 610,992 | |
| $0.177 | -0.003 | -1.4% | $0.180 | $0.182 | $0.176 | 482,807 | |
| $0.180 | +0.000 | +0.2% | $0.181 | $0.183 | $0.177 | 424,175 | |
| $0.180 | -0.003 | -1.8% | $0.184 | $0.185 | $0.177 | 483,766 | |
| $0.183 | +0.000 | +0.2% | $0.182 | $0.187 | $0.181 | 547,517 | |
| $0.183 | -0.008 | -3.9% | $0.190 | $0.191 | $0.182 | 672,523 | |
| $0.190 | +0.010 | +5.6% | $0.190 | $0.193 | $0.180 | 1,126,397 | |
| $0.180 | -0.008 | -4.1% | $0.190 | $0.193 | $0.177 | 1,331,531 | |
| $0.188 | +0.013 | +7.3% | $0.179 | $0.189 | $0.175 | 848,077 | |
| $0.175 | +0.002 | +0.9% | $0.177 | $0.182 | $0.173 | 984,768 | |
| $0.174 | -0.011 | -5.9% | $0.184 | $0.184 | $0.166 | 2,631,465 | |
| $0.184 | -0.006 | -3.0% | $0.188 | $0.192 | $0.182 | 1,337,884 | |
| $0.190 | -0.013 | -6.5% | $0.201 | $0.202 | $0.187 | 1,918,222 | |
| $0.203 | -0.007 | -3.2% | $0.202 | $0.208 | $0.202 | 846,131 | |
| $0.210 | -0.006 | -2.6% | $0.211 | $0.211 | $0.205 | 1,444,483 | |
| $0.216 | +0.006 | +2.9% | $0.210 | $0.216 | $0.207 | 3,403,587 | |
| $0.210 | +0.002 | +1.0% | $0.214 | $0.214 | $0.201 | 1,490,809 | |
| $0.208 | -0.010 | -4.5% | $0.217 | $0.217 | $0.204 | 1,797,085 | |
| $0.217 | +0.005 | +2.5% | $0.206 | $0.218 | $0.205 | 2,212,869 | |
| $0.212 | -0.002 | -0.7% | $0.212 | $0.217 | $0.206 | 2,460,138 | |
| $0.214 | -0.009 | -4.2% | $0.225 | $0.225 | $0.212 | 1,917,646 | |
| $0.223 | +0.001 | +0.5% | $0.212 | $0.223 | $0.211 | 1,747,870 | |
| $0.222 | -0.005 | -2.3% | $0.221 | $0.224 | $0.215 | 3,357,457 | |
| $0.227 | -0.006 | -2.7% | $0.220 | $0.230 | $0.215 | 10,547,080 | |
| $0.233 | +0.004 | +1.5% | $0.229 | $0.237 | $0.227 | 9,027,757 | |
| $0.230 | +0.002 | +0.9% | $0.234 | $0.237 | $0.228 | 6,117,621 | |
| $0.228 | -0.006 | -2.6% | $0.233 | $0.240 | $0.227 | 9,319,419 | |
| $0.234 | -0.001 | -0.4% | $0.250 | $0.262 | $0.234 | 20,678,447 | |
| $0.235 | -0.001 | -0.6% | $0.230 | $0.247 | $0.227 | 8,857,914 | |
| $0.236 | +0.010 | +4.4% | $0.240 | $0.249 | $0.227 | 38,633,527 | |
| $0.226 | -0.032 | -12.5% | $0.371 | $0.371 | $0.202 | 126,112,305 | |
| $0.258 | +0.008 | +3.4% | $0.256 | $0.260 | $0.250 | 340,564 | |
| $0.250 | 0.000 | 0.0% | $0.252 | $0.258 | $0.249 | 466,565 | |
| $0.250 | -0.004 | -1.6% | $0.251 | $0.258 | $0.250 | 387,666 | |
| $0.254 | 0.000 | 0.0% | $0.254 | $0.262 | $0.250 | 659,576 | |
| $0.254 | -0.004 | -1.7% | $0.258 | $0.258 | $0.247 | 424,117 | |
| $0.258 | +0.005 | +2.1% | $0.263 | $0.270 | $0.254 | 877,273 | |
| $0.253 | +0.015 | +6.3% | $0.243 | $0.259 | $0.239 | 590,075 | |
| $0.238 | +0.004 | +1.8% | $0.240 | $0.259 | $0.238 | 1,157,982 | |
| $0.234 | -0.009 | -3.7% | $0.244 | $0.256 | $0.234 | 459,681 | |
| $0.243 | +0.023 | +10.5% | $0.230 | $0.258 | $0.226 | 2,109,034 | |
| $0.220 | -0.039 | -15.0% | $0.250 | $0.260 | $0.190 | 1,848,227 | |
| $0.259 | +0.002 | +0.6% | $0.259 | $0.262 | $0.255 | 426,898 | |
| $0.257 | +0.002 | +0.9% | $0.254 | $0.263 | $0.246 | 874,912 | |
| $0.255 | -0.008 | -3.2% | $0.260 | $0.263 | $0.246 | 1,550,755 | |
| $0.263 | -0.022 | -7.8% | $0.264 | $0.280 | $0.260 | 1,868,899 | |
| $0.285 | +0.015 | +5.4% | $0.264 | $0.290 | $0.261 | 1,061,981 | |
| $0.271 | -0.013 | -4.5% | $0.285 | $0.300 | $0.265 | 3,578,678 | |
| $0.284 | +0.021 | +7.8% | $0.263 | $0.300 | $0.251 | 6,205,087 | |
| $0.263 | -0.001 | -0.4% | $0.270 | $0.270 | $0.243 | 1,266,474 | |
| $0.264 | +0.010 | +4.1% | $0.269 | $0.270 | $0.252 | 1,925,999 | |
| $0.254 | +0.019 | +7.9% | $0.244 | $0.275 | $0.240 | 3,653,101 | |
| $0.235 | -0.005 | -2.1% | $0.238 | $0.245 | $0.235 | 376,593 |
- Ticker
- NYSE American:AIM
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NYSE American
- Currency
- USD
What changed lately
Latest news release · Sep 3, 2026
AIM ImmunoTech Significantly Expands Ampligen Global Patent Estate with Long COVID Protection across Europe and the United Kingdom Through 2041
Latest deck · Jun 4, 2026
Technical Presentation (June 2026)
Technical · 10 slides
Calls
Replays
AIM Immunotech (NYSE American: AIM) Q2 2025 Earnings Call
Wed, Aug 20, 2025 · 2:40 PM ET
Watch TranscriptAIM Immunotech (NYSE American: AIM) Q4 2024 Earnings Call
Tue, Apr 01, 2025 · 8:30 AM ET
Watch TranscriptAIM Immunotech (NYSE American: AIM) Q3 2024 Earnings Call
Fri, Nov 15, 2024 · 8:30 AM ET
Watch Transcript
Latest news
AIM ImmunoTech Significantly Expands Ampligen Global Patent Estate with Long COVID Protection across Europe and the United Kingdom Through 2041
Sep 3, 2026
Closed $0.234 (-0.4%) on Sep 3, 2026
AIM ImmunoTech Reports Second Quarter 2026 Financial Results and Highlights Significant Operational Execution Advancing Ampligen(R) Toward Planned Phase 3 Development in Pancreatic Cancer
Aug 11, 2026
Closed $0.255 (-3.2%) on Aug 11, 2026
AIM ImmunoTech Reports Second Quarter 2026 Financial Results and Highlights Significant Operational Execution Advancing Ampligen® Toward Planned Phase 3 Development in Pancreatic Cancer
Aug 10, 2026
Closed $0.263 (-7.8%) on Aug 10, 2026
Ahead of Schedule on 'Last Dose' DURIPANC Critical Clinical Inflection Point
Aug 3, 2026
Closed $0.264 (+4.1%) on Aug 3, 2026
AIM ImmunoTech Announces Release of New CEO Corner Segment Highlighting Growing Momentum Across Pancreatic Cancer Program
Jul 7, 2026
Closed $0.306 (+2.9%) on Jul 7, 2026
AIM ImmunoTech Accelerates Toward Potential Pivotal Pancreatic Cancer Program as Ampligen Continues to Advance Through Key Clinical Milestones
Jun 24, 2026
Closed $0.374 (+3.0%) on Jun 24, 2026
AIM ImmunoTech Achieves Clinical Milestone as Final Subject Receives First Dose in Phase 2 DURIPANC Study in Metastatic Pancreatic Cancer
Jun 18, 2026
Closed $0.38 (-5.0%) on Jun 18, 2026
AIM ImmunoTech Regains NYSE American Compliance, Company Resolves Stockholder Equity Deficiency
Jun 15, 2026
Closed $0.388 (-4.4%) on Jun 15, 2026
AIM ImmunoTech Announces $2.65 Million Financing Priced At-Market under NYSE American Rules
Jun 9, 2026
Closed $0.403 (-22.3%) on Jun 9, 2026
Decks
Technical Presentation (June 2026)
Technical · 10 slides · Jun 4, 2026
Investor Presentation (February 2026)
Investor deck · 17 slides · Feb 5, 2026
Investor Presentation (January 2026)
Investor deck · 29 slides · Jan 12, 2026
Maxim Growth Conference Oct. 22-23, 2025
Conference · 20 slides · Oct 20, 2025
AIM ImmunoTech Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 42 in the last 12 months · 58 in all · newest Sep 3, 2026 · oldest 2025
- Calls
- 10 calls with a replay · 10 with a transcript · latest Aug 20, 2025
- Decks
- 33 decks · latest Jun 4, 2026
Where AIM ImmunoTech Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NYSE American:AIM · Home listing · This page | NYSE American | United States | USD |
| BOATS:AIM | BOATS | United States | USD |
| LSE:0A4Y | LSE | United Kingdom | USD |
| gettex:HXB | gettex | Germany | EUR |
| Frankfurt:HXB | Frankfurt | Germany | EUR |
| Lang & Schwarz:A2PREX | Lang & Schwarz | Germany | EUR |
| Lang & Schwarz:A416YS | Lang & Schwarz | Germany | EUR |
| LS Exchange:A2PREX | LS Exchange | Germany | EUR |
| LS Exchange:A416YS | LS Exchange | Germany | EUR |
| Munich:HXB | Munich | Germany | EUR |
Log in to ask 6ix AI your own questions about AIM ImmunoTech Inc.